Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Middle East & Africa Blood Coagulants Market Research Report Information, By Types (Coagulation Factor, others), Indication (Haemophilia, Surgery, other Bleeding Disorders) -Forecast till 2030


ID: MRFR/Pharma/2027-CR | 53 Pages | Author: Kinjoll Dey| July 2017
Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

1 Report Prologue

2 Research Methodology

2.1 Research Process 10

2.2 Primary Research 11

2.3 Secondary Research 11

2.4 Market Size Estimation 11

2.5 Forecast Model 12

3 Market Dynamics

3.1 Introduction 13

3.2 Drivers 14

3.2.1 Bleeding Disorder And Related Conditions Will Push The Demands On Health Systems (Impact Weightage 75%) 14

3.2.2 Rising Funding, Healthcare Insurance Coverage, And Awareness Programs For Bleeding Disorders Are Expected To Boost The Growth Of The Market (Impact Weightage 25%) 15

3.3 Restrains 16

3.3.1 Lack Of R&D Capabilities: (Impact Weightage 45%) 16

3.3.2 Counterfeit Drugs (Impact Weightage 35%) 17

3.3.3 Lack Of Awareness (Impact Weightage 20%) 18

4 Middle East & Africa Blood Coagulants Market By Type

4.1 Introduction 19

4.2 Coagulation Factor 22

4.2.1 Recombinant Coagulation Factor 23

4.2.2 Plasma Derived Coagulation Factor 24

5 Middle East & Africa Blood Coagulants Market, By Indication

5.1 Introduction 25

5.2 Haemophilia 27

5.3 Surgery 28

5.4 Other Bleeding Disorders 29

6 Middle East & Africa Blood Coagulants Market, By Country

6.1 Introduction 30

6.2 Saudi Arabia (KSA) 32

Middle East & Africa Blood Coagulants Market, By Indication

6.3 United Arab Emirates (UAE) 34

Middle East & Africa Blood Coagulants Market, By Indication

6.4 Qatar 36

Middle East & Africa Blood Coagulants Market, By Indication

6.5 Oman 38

Middle East & Africa Blood Coagulants Market, By Indication

6.6 Kuwait 40

Middle East & Africa Blood Coagulants Market, By Indication

6.7 Egypt 42

Middle East & Africa Blood Coagulants Market, By Indication

6.8 Rest Of Middle East & Africa 44

Middle East & Africa Blood Coagulants Market, By Indication

7 Company Profiles

7.1 Pfizer 46

7.1.1 Company Overview 46

7.1.2 Financials 46

7.1.3 Products 46

7.1.4 Strategies 46

7.1.5 Key Developments 46

7.2 Bayer AG 47

7.2.1 Company Overview 47

7.2.2 Financials 47

7.2.3 Products 47

7.2.4 Strategies 47

7.2.5 Key Developments 47

7.3 Novo Nordisk AS 48

7.3.1 Company Overview 48

7.3.2 Financials 48

7.3.3 Products 48

7.3.4 Strategies 48

7.3.5 Key Developments 48

7.4 Shire 49

7.4.1 Company Overview 49

7.4.2 Financials 49

7.4.3 Products 49

7.4.4 Strategies 49

7.5 SOBI 50

7.5.1 Company Overview 50

7.5.2 Financials 50

7.5.3 Products 50

7.5.4 Strategies 50

7.5.5 Key Developments 50

7.6 Octapharma 51

7.6.1 Company Overview 51

7.6.2 Financials 51

7.6.3 Products 51

7.6.4 Strategies 51

7.6.5 Key Developments 51

7.7 CSL Limited 52

7.7.1 Company Overview 52

7.7.2 Financials 52

7.7.3 Products 52

7.7.4 Strategies 52

7.7.5 Key Developments 52

8 List Of Tables

TABLE 1 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 20

TABLE 2 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 21

TABLE 3 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY COUNTRIES, 2023 TO 2030 (USD MILLION) 22

TABLE 4 MIDDLE EAST & AFRICA RECOMBINANT COAGULATION FACTOR MARKET BY COUNTRIES,

2023 TO 2030 (USD MILLION) 23

TABLE 5 MIDDLE EAST & AFRICA PLASMA DERIVED COAGULATION FACTOR MARKET BY COUNTRIES,

2023 TO 2030 (USD MILLION) 24

TABLE 6 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY INDICATION, 2023 TO 2030 (USD MILLION) 26

TABLE 7 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR HAEMOPHILIA BY COUNTRY,

2023 TO 2030 (USD MILLION) 27

TABLE 8 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR SURGERY BY COUNTRY,

2023 TO 2030 (USD MILLION) 28

TABLE 9 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET FOR OTHER BLEEDING DISORDERS BY COUNTRY,

2023 TO 2030 (USD MILLION) 29

TABLE 10 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET, BY COUNTRY, 2023 TO 2030 (USD MILLION) 31

TABLE 11 SAUDI ARABIA BLOOD COAGULANTS MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 32

TABLE 12 SAUDI ARABIA COAGULATION FACTOR MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 32

TABLE 13 SAUDI ARABIA BLOOD COAGULANTS MARKET BY INDICATION, 2023 TO 2030 (USD MILLION) 33

TABLE 14 UNITED ARAB EMIRATES BLOOD COAGULANTS MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 34

TABLE 15 UNITED ARAB EMIRATES COAGULATION FACTOR MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 34

TABLE 16 UNITED ARAB EMIRATES BLOOD COAGULANTS MARKET BY INDICATION, 2023 TO 2030 (USD MILLION) 35

TABLE 17 QATAR BLOOD COAGULANTS MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 36

TABLE 18 QATAR COAGULATION FACTOR MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 36

TABLE 19 QATAR BLOOD COAGULANTS MARKET BY INDICATION, 2023 TO 2030 (USD MILLION) 37

TABLE 20 OMAN BLOOD COAGULANTS MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 38

TABLE 21 OMAN COAGULATION FACTOR MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 38

TABLE 22 OMAN BLOOD COAGULANTS MARKET BY INDICATION, 2023 TO 2030 (USD MILLION) 39

TABLE 23 KUWAIT BLOOD COAGULANTS MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 40

TABLE 24 KUWAIT COAGULATION FACTOR MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 40

TABLE 25 KUWAIT BLOOD COAGULANTS MARKET BY INDICATION, 2023 TO 2030 (USD MILLION) 41

TABLE 26 EGYPT BLOOD COAGULANTS MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 42

TABLE 27 EGYPT COAGULATION FACTOR MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 42

TABLE 28 EGYPT BLOOD COAGULANTS MARKET BY INDICATION, 2023 TO 2030 (USD MILLION) 43

TABLE 29 REST OF MEA BLOOD COAGULANTS MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 44

TABLE 30 REST OF MEA COAGULATION FACTOR MARKET BY TYPE, 2023 TO 2030 (USD MILLION) 44

TABLE 31 REST OF MEA BLOOD COAGULANTS MARKET BY INDICATION, 2023 TO 2030 (USD MILLION) 45

9 List Of Figures

FIGURE 1 RESEARCH PROCESS OF MRFR 10

FIGURE 2 MIDDLE EAST & AFRICA MARKET: FORECAST MODEL 12

FIGURE 3 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY TYPE, 2023 & 2030 (USD MILLION) 19

FIGURE 4 MIDDLE EAST & AFRICA COAGULATION FACTOR MARKET BY TYPE, 2023 & 2030 (USD MILLION) 20

FIGURE 5 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET BY INDICATION, 2023 & 2030 (USD MILLION) 25

FIGURE 6 MIDDLE EAST & AFRICA BLOOD COAGULANTS MARKET, BY COUNTRY, 2023 & 2030 (USD MILLION) 30

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.